Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome Survivors: Long-term Follow-up
Overview
Authors
Affiliations
Background: Short-term follow-up studies of severe acute respiratory syndrome (SARS) survivors suggested that their physical conditions continuously improved in the first year but that their mental health did not. We investigated long-term psychiatric morbidities and chronic fatigue among SARS survivors.
Methods: All SARS survivors from the hospitals of a local region in Hong Kong were assessed by a constellation of psychometric questionnaires and a semistructured clinical interview for the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) to determine the presence of psychiatric disorders and chronic fatigue problems.
Results: Of 369 SARS survivors, 233 (63.1%) participated in the study (mean period of time after SARS, 41.3 months). Over 40% of the respondents had active psychiatric illnesses, 40.3% reported a chronic fatigue problem, and 27.1% met the modified 1994 Centers for Disease Control and Prevention criteria for chronic fatigue syndrome. Logistic regression analysis suggested that being a health care worker at the time of SARS infection (odds ratio [OR], 3.24; 95% confidence interval [CI], 1.12- 9.39; P = .03), being unemployed at follow-up (OR, 4.71; 95% CI, 1.50-14.78; P = .008), having a perception of social stigmatization (OR, 3.03; 95% CI, 1.20-7.60; P = .02), and having applied to the SARS survivors' fund (OR, 2.92; 95% CI, 1.18-7.22; P = .02) were associated with an increased risk of psychiatric morbidities at follow-up, whereas application to the SARS survivors' fund (OR, 2.64; 95% CI, 1.07-6.51; P = .04) was associated with increased risk of chronic fatigue problems.
Conclusions: Psychiatric morbidities and chronic fatigue persisted and continued to be clinically significant among the survivors at the 4-year follow-up. Optimization of the treatment of mental health morbidities by a multidisciplinary approach with a view for long-term rehabilitation, especially targeting psychiatric and fatigue problems and functional and occupational rehabilitation, would be needed.
Escoda T, Chiche L, Faralli H, Cohen F, Halfon P, Pegliasco H BMJ Open. 2025; 15(2):e089136.
PMID: 39933809 PMC: 11815462. DOI: 10.1136/bmjopen-2024-089136.
Alie M, Tesema G, Abebe G, Girma D Front Public Health. 2025; 13:1415427.
PMID: 39925756 PMC: 11803863. DOI: 10.3389/fpubh.2025.1415427.
Alhasan R, Rafsten L, Larsson A, Sunnerhagen K, Persson H Front Cell Neurosci. 2025; 18():1460119.
PMID: 39835287 PMC: 11743663. DOI: 10.3389/fncel.2024.1460119.
Association between chronic fatigue syndrome/myalgic encephalomyelitis and cardiovascular disease.
Denu M, Revoori R, Eghan C, Larbi Kwapong F, Hillman A, Normeshie C Sci Rep. 2025; 15(1):2294.
PMID: 39833264 PMC: 11747618. DOI: 10.1038/s41598-025-86609-4.
Pacnejer A, Butuca A, Dobrea C, Arseniu A, Frum A, Gligor F Viruses. 2025; 16(12.
PMID: 39772122 PMC: 11680421. DOI: 10.3390/v16121811.